Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: €3.78 M
• Last 3 months FTD volume: €6.05 M
• Last year FTD volume: €6.05 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€3.47 M	€65.4 M	🇺🇸 USA
Royalty Pharma RPRX	€6.29 M	€12.28 M	🇬🇧 UK
Palatin Technologies PTN	€0.12 M	€2.19 M	🇺🇸 USA
Eli Lilly LLY	€42.55 M	€0.15 B	🇺🇸 USA
AbbVie ABBV	€72.85 M	€0.15 B	🇺🇸 USA
Pfizer PFE	€0.18 B	€0.53 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	€1.9 M	€2.39 M	🇺🇸 USA
Athersys ATHX	€0.09 M	€0.71 M	🇺🇸 USA